Subscribe to thousands of academic journals for just $40/month
Read and share the articles you need for your research, all in one place.

The Drug Metabolism Discussion Group

Xenobiotica , Volume 11 (12) – Jan 1, 1981

Details

Publisher
Informa UK Ltd
Copyright
© 1981 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted
Subject
Original Article
ISSN
0049-8254
eISSN
1366-5928
D.O.I.
10.3109/00498258109045317
Publisher site
See Article on Publisher Site

Preview Only

Expand Tray Hide Tray

The Drug Metabolism Discussion Group

Abstract

XENOBIOTICA, 1981, VOL. 11, NO. 12, 801 The Drug Metabolism Discussion Group The idea of an industrial Drug Metabolism Discussion Group (DMDG) was first considered during the Second European Workshop on Drug Metabolism at the University of Surrey. Following these informal discussions, Alastair Monro (Pfizer) arranged a meeting in December 1971, to establish the D M D G . Representatives of nine drug companies attended and a committee was formed, consisting of Alastair Monro, David Foulkes (ICI), Bob Long (Roche) and Torben Hesselbo (SKF). The group planned to meet twice a year to discuss techniques used to study drug metabolism in industry. It was decided, therefore, to restrict membership to those working in the pharmaceutical industry. T o encourage informality, the proceedings would not be recorded and only two representatives from each company would be allowed to attend. The first scientific session was held at ICI Pharmaceuticals in May 1972, and considered topics such as the detection and measurement of labelled material in tissues, the use of radioisotopes in man and the role of g.1.c.-mass spectrometry. These limited-attendance meetings are still held on a regular basis. In 1975, however, the group expanded its activities. So that more people
Loading next page...

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/informa-healthcare/the-drug-metabolism-discussion-group-h8zA8ulq4l